Traditional Chinese medicine preparation for treating palpitaition

Abstract

The invention relates to the technical field of medicine, and concretely relates to a traditional Chinese medicine for treating palpitaition. The traditional Chinese medicine preparation comprises the following raw materials by weight part: 8-12 parts of Tuber of Dwarf Lilyturf, 10-14 parts of jujube, 8-10 parts of polyghace seche, 3-5 parts of Chinese magnoliavine, 10-20 parts of Ligusticum wallichii, 4-8 parts of pseudo-ginseng, 6-10 parts of gen-seng, 10-20 parts of Rehmannia Glutinosa, 10-20 parts of rehmanniae radix and 8-12 parts of sophora flavescens. The traditional Chinese medicine preparation has the advantages of fast effectiveness and no toxic and side effect.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a traditional Chinese medicine preparation for treating heart palpitations. Background technique [0002] Palpitation is a common symptom. Patients feel heartbeat or palpitation, accompanied by discomfort in the precordial area. When the heart rate is slow, they often feel strong heart fluctuations. When the heart rate is fast, they can feel the heart beating or even the vibration of the precordial area. Palpitations are generally transient and often occur due to mood swings or fatigue. Although the clinical diagnosis of this disease is relatively easy in modern medicine, its treatment and prognosis evaluation are more difficult. With the advancement of medicine, although the current interventional therapy may completely ablate the ectopic pacemaker, it is not suitable for most patients because the age of the patients tends to age, and the risk and treatment cost increase. Ther...

AI Technical Summary

Problems solved by technology

Although the clinical diagnosis of this disease is relatively easy in modern medicine, its treatment and prognosis evaluation are more difficult.

With the advancement of medicine, although the current interventional therapy may completely ablate the ectopic pacemaker, it is not suitable for most patients because the age of the patients tends to age, and the risk and treatment cost increase. Therefore, the current antiarrhythmic drugs are still is the main line of treatment

However, due to the arrhythmogenic effect of antiarrhythmic western medicine itself and the potential danger of inhibiting the normal physiological activity of the heart, its clinical tolerance and compliance are poor; in addition, its electrophysiological effect is single, so its application range is limited limit